long half-life and large variability [Regulatives / Guidelines]

posted by Achievwin – US, 2020-08-12 17:22 (953 d 02:28 ago) – Posting: # 21864
Views: 1,513

Welcome to the home of funky and funny pharmacokinetics where "Garbage in Gospel out" is day of life.

1. allowing long washout periods have seen studies with 4 -5 months washout.
2. other choice we can imagine is Two stage adaptive study design and including ANCOA in place of ANOVA...

want to know what other experts think?

❝ In short:


Complete thread:

UA Flag
Activity
 Admin contact
22,548 posts in 4,723 threads, 1,606 registered users;
23 visitors (0 registered, 23 guests [including 11 identified bots]).
Forum time: 18:51 CET (Europe/Vienna)

You can’t really say “similar” if it’s the same again you want.
“Similar” means something different.    Anthony Burgess

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5